Royce & Associates LP Celcuity Inc. Transaction History

Royce & Associates LP

  • $10.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 13, 2018
SELL
$20.96 - $30.77 $775,520 - $1.14 Million
-37,000 Closed
0 $0
Q1 2018

May 14, 2018
SELL
$13.55 - $21.3 $1.02 Million - $1.6 Million
-75,000 Reduced 66.96%
37,000 $610,000
Q3 2017

Nov 13, 2017
BUY
$11.94 - $14.29 $1.34 Million - $1.6 Million
112,000
112,000 $1.37 Million

Others Institutions Holding CELC

# of Institutions
107
Shares Held
30.3M
Call Options Held
30.8K
Put Options Held
152K
View Full List

About Celcuity Inc.

CELC Quotes by TradingView
  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $208M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email